Latest filing published 03 Apr 2026 for Certara, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
John E. Gallagher (finance chief) discloses dealings in 2 companies, chiefly Cue Health Inc. and Certara, Inc. In total, 21 filings cover trades dated from 28 September 2021 to 1 April 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 3 April 2026, the filings show a share grant worth €26k in Certara, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations